Terms: = Kidney tumors AND HMGA2, HMGI-C, 8091, ENSG00000149948, LIPO, HMGIC, BABL
25 results:
1. Anti-cancer activity of microbubble conjugated with Sorafenib containing liposome and IL4R-targeting peptide in kidney cancer cells.
Lee J; Park SH
Cell Mol Biol (Noisy-le-grand); 2023 Dec; 69(14):266-271. PubMed ID: 38279420
[TBL] [Abstract] [Full Text] [Related]
2. circRARS synergises with IGF2BP3 to regulate RNA methylation recognition to promote tumour progression in renal cell carcinoma.
Liu Y; Chen K; Shou Y; Li S; Wang J; Zhang Q; Huang Z; Xu J; Li M; Liu D; Liang H; Yang H; Zhang X
Clin Transl Med; 2023 Dec; 13(12):e1512. PubMed ID: 38073586
[TBL] [Abstract] [Full Text] [Related]
3. Proteomic analysis identifies hmga2 as a novel biomarker of overall survival in papillary renal cell carcinoma.
Wei T; Xu H; Liang H; Lian Y; Chen H; Zheng Z; Zhong M; Liu J; Wang R; Wang F
Cancer Med; 2023 Jul; 12(13):14851-14864. PubMed ID: 37283291
[TBL] [Abstract] [Full Text] [Related]
4. NUF2 Drives Clear Cell Renal Cell Carcinoma by Activating hmga2 Transcription through KDM2A-mediated H3K36me2 Demethylation.
Lin J; Chen X; Yu H; Min S; Chen Y; Li Z; Xie X
Int J Biol Sci; 2022; 18(9):3621-3635. PubMed ID: 35813477
[TBL] [Abstract] [Full Text] [Related]
5. LncRNA SNHG1 promotes renal cell carcinoma progression through regulation of hmga2 via sponging miR-103a.
Ye ZH; Gui DW; Wang XY; Wang J; Fu JL
J Clin Lab Anal; 2022 Jun; 36(6):e24422. PubMed ID: 35466471
[TBL] [Abstract] [Full Text] [Related]
6. Effects of hmga2 on the epithelial-mesenchymal transition-related genes in ACHN renal cell carcinoma cells-derived xenografts in nude mice.
Liu Y; Lv G; Bai J; Song L; Ding E; Liu L; Tian Y; Chen Q; Li K; Liu X; Ding Y
BMC Cancer; 2022 Apr; 22(1):421. PubMed ID: 35439951
[TBL] [Abstract] [Full Text] [Related]
7. Effects of
Chen Q; Fu Q; Pu L; Liu X; Liu Y
J Int Med Res; 2022 Feb; 50(2):3000605221075511. PubMed ID: 35118889
[TBL] [Abstract] [Full Text] [Related]
8. The analysis of N6-methyladenosine regulators impacting the immune infiltration in clear cell renal cell carcinoma.
Li J; Cao J; Liang C; Deng R; Li P; Tian J
Med Oncol; 2022 Jan; 39(4):41. PubMed ID: 35092501
[TBL] [Abstract] [Full Text] [Related]
9. Combination immunotherapy of oncolytic virus nanovesicles and PD-1 blockade effectively enhances therapeutic effects and boosts antitumour immune response.
Ji W; Li L; Zhou S; Qiu L; Qian Z; Zhang H; Zhao P
J Drug Target; 2020 Nov; 28(9):982-990. PubMed ID: 32379004
[TBL] [Abstract] [Full Text] [Related]
10. Preparation, characterization, pharmacokinetics and anticancer effects of PEGylated β-elemene liposomes.
Zhai B; Wu Q; Wang W; Zhang M; Han X; Li Q; Chen P; Chen X; Huang X; Li G; Zhang Q; Zhang R; Xiang Y; Liu S; Duan T; Lou J; Xie T; Sui X
Cancer Biol Med; 2020 Feb; 17(1):60-75. PubMed ID: 32296587
[No Abstract] [Full Text] [Related]
11. hmga2 gene polymorphisms and Wilms tumor susceptibility in Chinese children: a four-center case-control study.
Cheng J; Zhuo Z; Yang L; Zhao P; Zhang J; Zhou H; He J; Li P
Biotechnol Appl Biochem; 2020 Nov; 67(6):939-945. PubMed ID: 31746066
[TBL] [Abstract] [Full Text] [Related]
12. MicroRNA-599 targets high-mobility group AT-hook 2 to inhibit cell proliferation and invasion in clear cell renal carcinoma.
Zhao H; Zhao H; Xia X; Liu X
Mol Med Rep; 2018 May; 17(5):7451-7459. PubMed ID: 29568870
[TBL] [Abstract] [Full Text] [Related]
13. miR‑539 suppresses proliferation and induces apoptosis in renal cell carcinoma by targeting high mobility group A2.
Ye ZH; Gui DW
Mol Med Rep; 2018 Apr; 17(4):5611-5618. PubMed ID: 29436648
[TBL] [Abstract] [Full Text] [Related]
14. hmga2 facilitates epithelial-mesenchymal transition in renal cell carcinoma by regulating the TGF-β/Smad2 signaling pathway.
Kou B; Liu W; Tang X; Kou Q
Oncol Rep; 2018 Jan; 39(1):101-108. PubMed ID: 29138866
[TBL] [Abstract] [Full Text] [Related]
15. Effect of RNA interference of the expression of hmga2 on the proliferation and invasion ability of ACHN renal cell carcinoma cells.
Liu Y; Fu QZ; Pu L; Song LL; Wang YY; Liu J; Wang ZL; Wang ZM
Mol Med Rep; 2017 Oct; 16(4):5107-5112. PubMed ID: 28849119
[TBL] [Abstract] [Full Text] [Related]
16. [Expression and clinical significance of hmga2 in renal carcinoma].
Liu Y; Fu QZ; Pu L; Song LL; Lyu GY; Liu J; Wang Z; Wang Z
Zhonghua Zhong Liu Za Zhi; 2017 Feb; 39(2):127-132. PubMed ID: 28219208
[No Abstract] [Full Text] [Related]
17. Mesenchymal Tumorigenesis Driven by TSC2 Haploinsufficiency Requires hmga2 and Is Independent of mTOR Pathway Activation.
D'Armiento J; Shiomi T; Marks S; Geraghty P; Sankarasharma D; Chada K
Cancer Res; 2016 Feb; 76(4):844-54. PubMed ID: 26837766
[TBL] [Abstract] [Full Text] [Related]
18. Nuclear death receptor TRAIL-R2 inhibits maturation of let-7 and promotes proliferation of pancreatic and other tumor cells.
Haselmann V; Kurz A; Bertsch U; Hübner S; Olempska-Müller M; Fritsch J; Häsler R; Pickl A; Fritsche H; Annewanter F; Engler C; Fleig B; Bernt A; Röder C; Schmidt H; Gelhaus C; Hauser C; Egberts JH; Heneweer C; Rohde AM; Böger C; Knippschild U; Röcken C; Adam D; Walczak H; Schütze S; Janssen O; Wulczyn FG; Wajant H; Kalthoff H; Trauzold A
Gastroenterology; 2014 Jan; 146(1):278-90. PubMed ID: 24120475
[TBL] [Abstract] [Full Text] [Related]
19. New self-assembly nanoparticles and stealth liposomes for the delivery of zoledronic acid: a comparative study.
Marra M; Salzano G; Leonetti C; Porru M; Franco R; Zappavigna S; Liguori G; Botti G; Chieffi P; Lamberti M; Vitale G; Abbruzzese A; La Rotonda MI; De Rosa G; Caraglia M
Biotechnol Adv; 2012; 30(1):302-9. PubMed ID: 21741464
[TBL] [Abstract] [Full Text] [Related]
20. [Pharmacodynamics, pharmacokinetics and tissue distribution of liposomal mitoxantrone hydrochloride].
Wang CX; Li CL; Zhao X; Yang HY; Wei N; Li YH; Zhang L; Zhang L
Yao Xue Xue Bao; 2010 Dec; 45(12):1565-9. PubMed ID: 21351498
[TBL] [Abstract] [Full Text] [Related]
[Next]
